Left Ventricular End-diastolic Pressure-guided Hydration for the Prevention of Contrast-induced Acute Kidney Injury in Patients with Stable Ischemic Heart Disease: the LAKESIDE Trial

Overview

Journal Int Urol Nephrol

Publisher Springer

Specialty Nephrology

Date 2019 Jul 24

PMID 31332700

Citations 8

Authors

Armin Marashizadeh

Hamid Reza Sanati

Parham Sadeghipour

Mohamad Mehdi Peighambari

Jamal Moosavi

Omid Shafe

Ata Firouzi

Ali Zahedmehr

Mohsen Maadani

Farshad Shakerian

Reza Kiani

Bahram Mohebbi

Mohammad Javad Alemzadeh-Ansari

Reza Tahvili

Batoul Naghavi

Affiliations

Soon will be listed here.

Abstract

Objectives: Contrast-induced acute kidney injury (CI-AKI) is a serious complication in patients undergoing diagnostic cardiac angiography or percutaneous coronary intervention. We aimed to evaluate the preventive effects of left ventricular end-diastolic pressure (LVEDP)-guided hydration for the prevention of CI-AKI in patients with chronic kidney disease undergoing cardiac catheterization.

Methods: This prospective randomized single-blind clinical trial enrolled 114 eligible patients with an estimated glomerular filtration rate (eGFR) of 15 < eGFR ≤ 60 mL/min/1.73 m [according to the level-modified Modification of Diet in Renal Disease formula (MDRD)] and stable ischemic heart disease undergoing coronary procedures. The patients were randomly allocated 1:1 into the LVEDP-guided hydration group (n = 57) or the standard hydration group (n = 57). CI-AKI was defined as a greater than 25% or greater than 0.5 mg/dL (44.2 mmol/L) increase in the serum creatinine concentration compared with the baseline value. Hydration with 0.9% sodium chloride at a rate of 1 mL/kg/h (0.5 mL/kg/h if left ventricular ejection fraction < 40%) within 12 h was given to all the patients in both groups before the procedure. In the LVEDP-guided group, the hydration infusion rate was adjusted according to the LVEDP level during and after the procedure.

Results: The incidence of CI-AKI was 7.01% (4/57) in the LVEDP-guided group vs 3.84% (2/52) in the standard hydration group (summary odds ratio 0.53, 95% CI 0.093-3.022; P = 0.463). Major adverse cardiac events, hemodialysis, or related deaths occurred in neither of the groups during hospitalization or the 30-day follow-up.

Conclusions: In the present study, LVEDP-guided fluid administration, by comparison with standard hydration, failed to offer protection against the risk of CI-AKI in patients with renal insufficiency undergoing coronary angiography with or without percutaneous coronary intervention.

Citing Articles

Navigating nephrotoxic waters: A comprehensive overview of contrast-induced acute kidney injury prevention.

Theofilis P, Kalaitzidis R World J Radiol. 2024; 16(6):168-183.

PMID: 38983842 PMC: 11229940. DOI: 10.4329/wjr.v16.i6.168.

Impact of angiotensin receptor blocker as antihypertensive in assessing mortality in patients of COVID-19: A single tertiary care center study.

Acharya S, Kumar S, Kabra R, Patel M, Phate N, Talwar D J Educ Health Promot. 2023; 12:30.

PMID: 37034857 PMC: 10079203. DOI: 10.4103/jehp.jehp_922_22.

Contrast-Induced Acute Kidney Injury: Evidence in Support of Its Existence and a Review of Its Pathogenesis and Management.

Chaudhari H, Mahendrakar S, Baskin S, Reddi A Int J Nephrol Renovasc Dis. 2022; 15:253-266.

PMID: 36311164 PMC: 9604418. DOI: 10.2147/IJNRD.S371700.

Scoring systems of kidney donation from deceased donors: A systematic review.

Moghbeli F, Jangi M, Ebnehoseini Z J Educ Health Promot. 2022; 10:456.

PMID: 35233403 PMC: 8826869. DOI: 10.4103/jehp.jehp_1657_20.

Trends in incidence and long-term prognosis of acute kidney injury following coronary angiography in Chinese cohort with 11,943 patients from 2013 to 2017: an observational study.

Liu J, Li Q, Lai D, Chen G, Wang B, Liu L BMC Nephrol. 2021; 22(1):235.

PMID: 34172005 PMC: 8235610. DOI: 10.1186/s12882-021-02427-6.

References

Mehran R, Aymong E, Nikolsky E, Lasic Z, Iakovou I, Fahy M . A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7):1393-9. DOI: 10.1016/j.jacc.2004.06.068. View

Nijssen E, Rennenberg R, Nelemans P, Essers B, Janssen M, Vermeeren M . Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017; 389(10076):1312-1322. DOI: 10.1016/S0140-6736(17)30057-0. View

Mehran R, Brar S, Dangas G . Contrast-induced acute kidney injury. Underappreciated or a new marker of cardiovascular mortality?. J Am Coll Cardiol. 2010; 55(20):2210-1. DOI: 10.1016/j.jacc.2009.12.051. View

Owen R, Hiremath S, Myers A, Fraser-Hill M, Barrett B . Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J. 2014; 65(2):96-105. DOI: 10.1016/j.carj.2012.11.002. View

McCullough P, Wolyn R, Rocher L, Levin R, ONeill W . Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997; 103(5):368-75. DOI: 10.1016/s0002-9343(97)00150-2. View

Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A . A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995; 333(16):1025-32. DOI: 10.1056/NEJM199510193331601. View

Maioli M, Toso A, Leoncini M, Musilli N, Grippo G, Ronco C . Bioimpedance-Guided Hydration for the Prevention of Contrast-Induced Kidney Injury: The HYDRA Study. J Am Coll Cardiol. 2018; 71(25):2880-2889. DOI: 10.1016/j.jacc.2018.04.022. View

Bagai A, Armstrong P, Stebbins A, Mahaffey K, Hochman J, Weaver W . Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study. Am Heart J. 2013; 166(5):913-9. DOI: 10.1016/j.ahj.2013.08.006. View

Giacoppo D, Gargiulo G, Buccheri S, Aruta P, Byrne R, Cassese S . Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients. Circ Cardiovasc Interv. 2017; 10(5). DOI: 10.1161/CIRCINTERVENTIONS.116.004383. View

10.

Weisbord S, Palevsky P . Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol. 2007; 3(1):273-80. DOI: 10.2215/CJN.02580607. View

11.

Neumann F, Sousa-Uva M, Ahlsson A, Alfonso F, Banning A, Benedetto U . 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018; 40(2):87-165. DOI: 10.1093/eurheartj/ehy394. View

12.

McCullough P, Choi J, Feghali G, Schussler J, Stoler R, Vallabahn R . Contrast-Induced Acute Kidney Injury. J Am Coll Cardiol. 2016; 68(13):1465-1473. DOI: 10.1016/j.jacc.2016.05.099. View

13.

Solomon R, Dauerman H . Contrast-induced acute kidney injury. Circulation. 2010; 122(23):2451-5. DOI: 10.1161/CIRCULATIONAHA.110.953851. View

14.

Brar S, Aharonian V, Mansukhani P, Moore N, Shen A, Jorgensen M . Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet. 2014; 383(9931):1814-23. DOI: 10.1016/S0140-6736(14)60689-9. View

15.

Laskey W, Jenkins C, Selzer F, Marroquin O, Wilensky R, Glaser R . Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol. 2007; 50(7):584-90. DOI: 10.1016/j.jacc.2007.03.058. View

16.

Reinecke H, Fobker M, Wellmann J, Becke B, Fleiter J, Heitmeyer C . A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial. Clin Res Cardiol. 2006; 96(3):130-9. DOI: 10.1007/s00392-007-0473-4. View

17.

Khwaja A . KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012; 120(4):c179-84. DOI: 10.1159/000339789. View

18.

Calvin A, Misra S, Pflueger A . Contrast-induced acute kidney injury and diabetic nephropathy. Nat Rev Nephrol. 2010; 6(11):679-88. PMC: 4476402. DOI: 10.1038/nrneph.2010.116. View

19.

Nash K, Hafeez A, Hou S . Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002; 39(5):930-6. DOI: 10.1053/ajkd.2002.32766. View

20.

Gruberg L, Mintz G, Mehran R, Gangas G, Lansky A, Kent K . The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000; 36(5):1542-8. DOI: 10.1016/s0735-1097(00)00917-7. View